Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Clinical symptoms, biochemistry, and liver histology during the native liver period of progressive familial intrahepatic cholestasis type 2

Fig. 2

Height and weight gain in Japanese PFIC2 patients with native liver. A Definition of the category of the follow-up time points. Init, the initial visit; End, the last visit (T01 and T02) or the last visit before LDLT (C01, C02, C03, C06, C08, and C10); Mid, visits between the initial and the end. B Height and weight gain. Height and weight were scored as z score based on the mean and SD of the Japanese population at each month’s age. The difference in z-score of height and weight between Init and Mid or End was calculated and plotted. The median z-score measured during the Mid-period was used for the Mid-values. Data concerning patients without NaPB therapy are shown as means with 95% CI (n = 6; C01, C02, C03, C06, C08, and C10). A grey horizontal and dotted line indicates 0

Back to article page